{"id":166574,"date":"2025-01-20T16:34:04","date_gmt":"2025-01-20T15:34:04","guid":{"rendered":"https:\/\/stratec-med.com\/literatur\/osteoporosis-in-children-and-adolescents-how-to-treat-and-monitor-2\/"},"modified":"2025-01-20T16:34:05","modified_gmt":"2025-01-20T15:34:05","slug":"osteoporosis-in-children-and-adolescents-how-to-treat-and-monitor-2","status":"publish","type":"literatur","link":"https:\/\/stratec-med.com\/en\/literature\/osteoporosis-in-children-and-adolescents-how-to-treat-and-monitor-2\/","title":{"rendered":"Osteoporosis in children and adolescents: how to treat and monitor?"},"content":{"rendered":"<p>Osteoporosis is a condition of increased bone fragility associated with  fractures. Apart from primary genetic osteoporotic conditions, secondary  osteoporosis in children is being increasingly recognized. As a result, there is  growing interest in its prevention and treatment. Important goals of care are to  prevent fractures, increase bone mass and trabecular and cortical thickness,  reshape vertebral fractures, prevent (or correct) skeletal deformities, and  improve mobility, independence, and quality of life. Secondary pediatric  osteoporosis is often of multifactorial origin since affected children frequently  have more than one acquired factor that is detrimental to bone health. Typical  conditions causing osteoporosis are leukemias, progressive muscle or neurological  disorders, as well as chronic inflammatory conditions and their treatment.  Management of children with osteoporosis involves a multidisciplinary team  involving pediatric experts from different subspecialties. With regard to  prevention and early intervention, it is important to provide optimal management  of any underlying systemic conditions including avoidance, or dose-reduction, of  osteotoxic medications. Basic supporting life-style measures, such as appropriate  nutrition, including adequate calcium intake and vitamin D, and physical activity  are recommended, where possible. When pediatric treatment criteria for  osteoporosis are met, antiresorptive drugs constitute the first pharmacological  line treatment. CONCLUSION: This clinical review focuses on the prevention,  treatment, and follow-up of children with, or at risk of developing, osteoporosis  and the transition from pediatric to adult care. WHAT IS KNOWN: * Osteoporosis  and associated fractures can cause significant morbidity and reduce the quality  of life. * The developing skeleton has huge potential for recovery and reshaping,  thus early detection of fractures, assessment of recovery potential, and  treatment of children with osteoporosis can prevent future fractures,  deformities, and scoliosis, improve function and mobility, and reduce pain. WHAT  IS NEW: * Osteoporosis in children and adolescents requires a multidisciplinary  approach with a thorough assessment of recovery potential, and indication for  therapy should be personalized. * Although bisphosphonates still represent the  drug most commonly used to increase bone mass, improve mobility, and reduce pain  and recurrence of fractures, new agents are being developed and could be  beneficial in children with specific conditions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Osteoporosis is a condition of increased bone fragility associated with fractures. Apart from primary genetic osteoporotic conditions, secondary osteoporosis in<\/p>\n","protected":false},"author":22,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false},"tags":[],"thema":[5878,5890,5856],"produktgruppe":[7527,5831],"literatur_kategorie":[7221],"class_list":["post-166574","literatur","type-literatur","status-publish","format-standard","hentry","thema-medical-applications","thema-paediatrics","thema-therapy-prevention-using-galileo","produktgruppe-galileo-en","produktgruppe-galileo-therapy","literatur_kategorie-clinical-studies"],"acf":[],"_links":{"self":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur\/166574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur"}],"about":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/types\/literatur"}],"author":[{"embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/users\/22"}],"version-history":[{"count":0,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur\/166574\/revisions"}],"wp:attachment":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/media?parent=166574"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/tags?post=166574"},{"taxonomy":"thema","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/thema?post=166574"},{"taxonomy":"produktgruppe","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/produktgruppe?post=166574"},{"taxonomy":"literatur_kategorie","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur_kategorie?post=166574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}